Natural History of the Progression of Choroideremia Study

NCT03359551 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 319

Last updated 2023-02-10

No results posted yet for this study

Summary

The objective of this natural history study is to gain a better understanding of the progression of choroideremia (CHM) and add to the knowledge base for this rare disease.

Conditions

  • Choroideremia

Sponsors & Collaborators

  • NightstaRx Ltd, a Biogen Company

    lead OTHER

Principal Investigators

  • Medical Director · Biogen

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2020-10-01
Completion
2020-10-01

Countries

  • United States
  • Brazil
  • Canada
  • Denmark
  • Finland
  • France
  • Germany
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03359551 on ClinicalTrials.gov